Institutional Ownership Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT). We have compiled data on the 215 institutions that hold shares in the stock, with a total of 133 Million shares, which have been reported (via 13F filing form) to have a value of $4.47 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
9,053,118
shares
|
$304 Million
2.42% of portfolio
|
Q3 2025
Added 242.89%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Nov 14, 2025 Q3 2025 |
9,003,418
shares
|
$302 Million
28.14% of portfolio
|
Q3 2025
Added 44.62%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
7,886,172
shares
|
$265 Million
9.57% of portfolio
|
Q3 2025
Reduced 7.14%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
7,757,662
shares
|
$260 Million
0.0% of portfolio
|
Q3 2025
Added 18.93%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,288,378
shares
|
$244 Million
0.0% of portfolio
|
Q2 2024
Added 8.95%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
7,250,000
shares
|
$243 Million
6.65% of portfolio
|
Q3 2025
Added 213.69%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
6,798,162
shares
|
$228 Million
10.94% of portfolio
|
Q3 2025
Reduced 2.39%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
4,775,419
shares
|
$160 Million
0.0% of portfolio
|
Q3 2025
Added 41.62%
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
4,000,000
shares
|
$134 Million
8.73% of portfolio
|
Q3 2025
Reduced 15.89%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,467,486
shares
|
$116 Million
0.67% of portfolio
|
Q3 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
3,274,155
shares
|
$110 Million
0.0% of portfolio
|
Q3 2025
Added 22.53%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
3,178,043
shares
|
$107 Million
0.02% of portfolio
|
Q3 2025
Added 10.62%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,156,398
shares
|
$106 Million
1.46% of portfolio
|
Q3 2025
Reduced 69.51%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,874,111
shares
|
$96.4 Million
13.45% of portfolio
|
Q3 2025
Added 4.02%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
2,789,137
shares
|
$93.5 Million
6.37% of portfolio
|
Q3 2025
Added 148.48%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
2,670,486
shares
|
$89.6 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
2,239,255
shares
|
$75.1 Million
0.0% of portfolio
|
Q3 2025
Added 59.84%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
2,209,118
shares
|
$74.1 Million
3.49% of portfolio
|
Q3 2025
Added 52.56%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2025 Q3 2025 |
2,127,941
shares
|
$71.4 Million
1.87% of portfolio
|
Q3 2025
Reduced 9.66%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
2,025,041
shares
|
$67.9 Million
6.38% of portfolio
|
Q3 2025
Reduced 11.86%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,853,672
shares
|
$62.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 47.32%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
1,724,279
shares
|
$57.8 Million
0.97% of portfolio
|
Q3 2025
Added 101.82%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,667,807
shares
|
$55.9 Million
0.0% of portfolio
|
Q3 2025
Added 168.47%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,659,677
shares
|
$55.7 Million
0.0% of portfolio
|
Q3 2025
Added 38.26%
|
|
|
Emerald Advisers, LLC
|
Oct 30, 2025 Q3 2025 |
1,579,496
shares
|
$53 Million
0.78% of portfolio
|
Q3 2025
Added 9.25%
|
|